直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • 联邦巡回法院知识产权博客
    • INCONTESTABLE® Blog
    • Prosecution First博客
  • Events & Webinars
  • 知识产权讯息
  • 播客
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Webinar

Recent Federal Circuit Cases Addressing Inequitable Conduct and the Duty of Candor

April 24, 2014

Webinar

View Webinar

Intellectual property lawyers need to keep current with the growing body of case law from the Federal Circuit. The Court’s decisions can affect a company’s IP portfolio strategy on many levels in significant, and sometimes subtle, ways. Some decisions have particular importance and deserve a closer look.

Please join our panelists as they discuss decisions related to inequitable conduct and the duty of candor before the U.S. Patent and Trademark Office (PTO) and its Patent Trial and Appeal Board (PTAB), including considerations for fulfilling the duty of candor in light of the America Invents Act’s (AIA) new post-grant proceedings and concurrent adjudication before the PTAB and in district court:

Ohio Willow Wood v. Alps South (2013)

The Court held that factual issues existed regarding whether Ohio Willow Wood’s counsel withheld material information and made material misrepresentations with intent to deceive during an appeal to the PTAB in a reexamination proceeding in light of discovery information in a parallel district court litigation.

Wireless v. HTC (2013)

The Court held that Intellect Wireless’s counsel had failed to cure false statements regarding an actual reduction to practice of the invention made by the inventor during prosecution before the PTO.

Network Signatures v. State Farm (2013)

In a split decision, the Court held that the use of a standard PTO form claiming unintentional delay in filing maintenance fees, without disclosing that the delay occurred pursuant to a policy of intentionally abandoning non-commercially viable inventions, did not establish withholding material information with intent to deceive.

Judge Clevenger dissented, arguing that materiality was established by the attorney’s use of the FDA form statement of unintentional delay without disclosure of the underlying facts and that the question of intent should go to trial.

Speakers

Michele C. Bosch 
Michael J. Flibbert

Date

Thursday, April 24, 2014

Time

1:00 - 2:00 p.m. EDT

Downloadable Files

  • Webinar: Recent Federal Circuit Cases Addressing Inequitable Conduct and the Duty of Candor

Related Practices

全球知识产权维权、诉讼与审判

联邦巡回法院和最高法院上诉

Related Professionals

Michele C. Bosch
Partner
Washington, DC
+1 202 408 4193
Email
Michael J. Flibbert
Partner
Washington, DC
+1 202 408 4493
Email

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP